BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

Linda Helbig, Lydia Koi, Kerstin Bruechner, Kristin Gurtner, Holger Hess-Stumpp, Kerstin Unterschemmann, Michael Baumann, Daniel Zips, Ala Yaromina

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number207
JournalRadiation Oncology
Volume9
DOIs
Publication statusPublished - 19 Sep 2014

Keywords

  • HIF pathway inhibition
  • Cisplatin
  • Fractionated radiation
  • Local tumor control
  • Tumor microenvironment
  • Human tumor xenograft

Cite this